GARTX | MAFIX | GARTX / MAFIX | |
Total Expense Ratio | 1.10 | 1.79 | 61% |
Annual Report Gross Expense Ratio | 1.23 | 1.87 | 66% |
Fund Existence | 17 years | 7 years | - |
Gain YTD | 0.420 | -10.274 | -4% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.71B | 899M | 524% |
Annual Yield % from dividends | 0.81 | 1.72 | 47% |
Returns for 1 year | 2.96 | -13.98 | -21% |
Returns for 3 years | 16.94 | -4.93 | -344% |
Returns for 5 years | 17.65 | 16.72 | 106% |
Returns for 10 years | 14.58 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CGTRX | 9.78 | 0.04 | +0.41% |
Columbia Select Large Cap Growth Inst2 | |||
DGIGX | 36.75 | 0.01 | +0.03% |
BNY Mellon Appreciation I | |||
LSMIX | 12.89 | -0.06 | -0.46% |
Loomis Sayles Small/Mid Cap Growth Instl | |||
PRMTX | 156.99 | -1.10 | -0.70% |
T. Rowe Price Comm & Tech Investor | |||
LYFCX | 11.57 | -0.19 | -1.62% |
AlphaCentric Life Sciences & Hlthcare C |